+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Pituitary-Adrenal Responsiveness during Lactation in Rats

      , ,


      S. Karger AG

      Lactation, ACTH, Corticosterone, Pituitary-adrenal, Diurnal rhythm, Stress response

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          The pituitary-adrenal system plays an important role in the initiation and maintenance of lactation in rats, with the suckling stimulus itself inducing the release of ACTH. The recent finding of a reduced plasma corticosterone response to a variety of noxious stimuli during lactation led us to further investigate the activity of this system in lactating (L) rats, compared with post-parturient non-lactating ontrols (NL). Plasma and adrenal corticosterone and plasma ACTH were measured, the latter with a mouse bioassay. Over a 24 h period (12 L:12 D), basal concentrations of plasma corticosterone were elevated in L females, only at those times when the NL basal concentrations were at the trough in the diurnal cycle. At all times, the plasma corticosterone increase 15 min after ether was significantly lower (by a mean of 55 %) in L rats than in NL rats. The elevations in plasma corticosterone after ether were higher for all rats during the day. The night-day difference in response to ether was greater in L rats than in NL rats. Although morning basal levels were not significantly elevated in L females deprived of their litters for 24 h, in these females, as in continually lactating rats, stress concentrations of plasma ACTH (2–4 min after ether) were one third that of the NL controls. Finally, after dexamethasone treatment, the corticosterone output to exogenous ACTH was lower in the plasma and higher in the adrenal in L rats. Thus, pituitary-adrenal activity is altered in a variety of ways during lactation.

          Related collections

          Author and article information

          S. Karger AG
          19 March 2008
          : 12
          : 3
          : 179-191
          Department of Psychiatry, Stanford University School of Medicine, Stanford, California
          122167 Neuroendocrinology 1973;12:179–191
          © 1973 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 13


          Comment on this article